Comments

Altimmune

ALTNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$6.28
-0.27-4.12%
At Close: -
$6.31
0.030.48%
After Hours: Jul 19, 7:57 PM EDT
15 minutes delayed
Altimmune (ALT) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$35.00
Lowest Price Target1
$12.00
Consensus Price Target1
$22.00

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Altimmune (NASDAQ:ALT) Stock, Analyst Ratings, Price Targets, Forecasts

Altimmune Inc has a consensus price target of $22 based on the ratings of 8 analysts. The high is $35 issued by Jefferies on August 31, 2022. The low is $12 issued by HC Wainwright & Co. on May 14, 2024. The 3 most-recent analyst ratings were released by B. Riley Securities, Piper Sandler, and HC Wainwright & Co. on June 25, 2024, June 21, 2024, and May 14, 2024, respectively. With an average price target of $19 between B. Riley Securities, Piper Sandler, and HC Wainwright & Co., there's an implied 201.11% upside for Altimmune Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
0
0
0
0
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B. Riley Securities
Piper Sandler
HC Wainwright & Co.
JMP Securities
Goldman Sachs

1calculated from analyst ratings

Analyst Ratings for Altimmune

Buy NowGet Alert
06/25/2024Buy Now216.96%B. Riley Securities
Mayank Mamtani
$20 → $20ReiteratesBuy → BuyGet Alert
06/21/2024Buy Now296.2%Piper Sandler
Yasmeen Rahimi
$25 → $25MaintainsOverweightGet Alert
05/14/2024Buy Now90.17%HC Wainwright & Co.
Patrick Trucchio
 → $12ReiteratesBuy → BuyGet Alert
05/10/2024Buy Now280.35%JMP Securities
Jonathan Wolleben
$25 → $24MaintainsMarket OutperformGet Alert
04/29/2024Buy Now—Guggenheim
Seamus Fernandez
—DowngradeBuy → NeutralGet Alert
04/01/2024Buy Now90.17%HC Wainwright & Co.
Patrick Trucchio
$15 → $12MaintainsBuyGet Alert
03/28/2024Buy Now216.96%B. Riley Securities
Mayank Mamtani
$20 → $20ReiteratesBuy → BuyGet Alert
02/13/2024Buy Now216.96%B. Riley Securities
Mayank Mamtani
 → $20MaintainsBuyGet Alert
01/24/2024Buy Now106.02%Goldman Sachs
Corinne Jenkins
 → $13Reinstates → NeutralGet Alert
12/01/2023Buy Now137.72%HC Wainwright & Co.
Patrick Trucchio
 → $15ReiteratesBuy → BuyGet Alert
11/09/2023Buy Now26.78%B. Riley Securities
Mayank Mamtani
$15 → $8MaintainsBuyGet Alert
08/14/2023Buy Now137.72%HC Wainwright & Co.
Patrick Trucchio
$50 → $15MaintainsBuyGet Alert
08/11/2023Buy Now137.72%B. Riley Securities
Mayank Mamtani
$20 → $15MaintainsBuyGet Alert
07/12/2023Buy Now137.72%JMP Securities
Jonathan Wolleben
 → $15ReiteratesMarket Outperform → Market OutperformGet Alert
05/15/2023Buy Now692.39%HC Wainwright & Co.
Patrick Trucchio
 → $50ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now137.72%JMP Securities
Jonathan Wolleben
$15 → $15ReinstatesMarket Outperform → Market OutperformGet Alert
03/31/2023Buy Now137.72%JMP Securities
Jonathan Wolleben
 → $15Reiterates → Market OutperformGet Alert
03/22/2023Buy Now312.04%JMP Securities
Jonathan Wolleben
 → $26Reiterates → Market OutperformGet Alert
03/22/2023Buy Now-4.91%Goldman Sachs
Corinne Jenkins
$20 → $6DowngradeBuy → NeutralGet Alert
03/09/2023Buy Now692.39%HC Wainwright & Co.
Patrick Trucchio
 → $50Reiterates → BuyGet Alert
02/06/2023Buy Now312.04%JMP Securities
Jonathan Wolleben
 → $26Reiterates → Market OutperformGet Alert
01/20/2023Buy Now692.39%HC Wainwright & Co.
Patrick Trucchio
 → $50Reiterates → BuyGet Alert
01/18/2023Buy Now296.2%Evercore ISI Group
Liisa Bayko
$14 → $25MaintainsOutperformGet Alert
12/01/2022Buy Now216.96%Goldman Sachs
Corinne Jenkins
 → $20Initiates → BuyGet Alert
11/11/2022Buy Now312.04%JMP Securities
Jonathan Wolleben
$28 → $26MaintainsMarket OutperformGet Alert
09/16/2022Buy Now312.04%Guggenheim
Seamus Fernandez
$31 → $26MaintainsBuyGet Alert
08/31/2022Buy Now454.68%Jefferies
Roger Song
$30 → $35MaintainsBuyGet Alert
08/17/2022Buy Now692.39%HC Wainwright & Co.
Patrick Trucchio
$25 → $50MaintainsBuyGet Alert
08/12/2022Buy Now312.04%B. Riley Securities
Mayank Mamtani
$21 → $26MaintainsBuyGet Alert
05/18/2022Buy Now296.2%Piper Sandler
Yasmeen Rahimi
$34 → $25MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Altimmune (ALT) stock?

A

The latest price target for Altimmune (NASDAQ:ALT) was reported by B. Riley Securities on June 25, 2024. The analyst firm set a price target for $20.00 expecting ALT to rise to within 12 months (a possible 216.96% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Altimmune (ALT)?

A

The latest analyst rating for Altimmune (NASDAQ:ALT) was provided by B. Riley Securities, and Altimmune reiterated their buy rating.

Q

When was the last upgrade for Altimmune (ALT)?

A

There is no last upgrade for Altimmune

Q

When was the last downgrade for Altimmune (ALT)?

A

The last downgrade for Altimmune Inc happened on April 29, 2024 when Guggenheim changed their price target from N/A to N/A for Altimmune Inc.

Q

When is the next analyst rating going to be posted or updated for Altimmune (ALT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Altimmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Altimmune was filed on June 25, 2024 so you should expect the next rating to be made available sometime around June 25, 2025.

Q

Is the Analyst Rating Altimmune (ALT) correct?

A

While ratings are subjective and will change, the latest Altimmune (ALT) rating was a reiterated with a price target of $20.00 to $20.00. The current price Altimmune (ALT) is trading at is $6.31, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch